Vertex Pharmaceuticals Inc
XBER:VX1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vertex Pharmaceuticals Inc
XBER:VX1
|
US |
|
Blue Owl Capital Corp
NYSE:OBDC
|
US |
|
E
|
Espey MFG and Electronics Corp
AMEX:ESP
|
US |
|
A
|
Archer-Daniels-Midland Co
F:ADM
|
US |
|
Kongsberg Gruppen ASA
F:KOZ0
|
NO |
|
Adobe Inc
NASDAQ:ADBE
|
US |
|
D
|
Deutsche Telekom AG
DUS:DTE
|
DE |
|
A
|
Archer-Daniels-Midland Co
XMUN:ADM
|
US |
|
Breville Group Ltd
ASX:BRG
|
AU |
|
Keppel Corporation Ltd
OTC:KPELF
|
SG |
|
A
|
AGBA Group Holding Ltd
F:D6D
|
HK |
|
Next Biometrics Group ASA
OSE:NEXT
|
NO |
|
Jollibee Foods Corp
OTC:JBFCF
|
PH |
|
Finolex Industries Ltd
NSE:FINPIPE
|
IN |
|
Sartorius Stedim Biotech SA
PAR:DIM
|
FR |
|
H
|
Hormel Foods Corp
XMUN:HO7
|
US |
|
F
|
Flight Centre Travel Group Ltd
F:FLI
|
AU |
Wall St Price Targets
VX1 Price Targets Summary
Vertex Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for VX1 is 483.71 EUR with a low forecast of 287.46 EUR and a high forecast of 580.47 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VX1's stock price target?
Price Target
483.71
EUR
According to Wall Street analysts, the average 1-year price target for VX1 is 483.71 EUR with a low forecast of 287.46 EUR and a high forecast of 580.47 EUR.
What is the Revenue forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 8 years is 10%.
What is the Gross Profit forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 8 years is 10%.
What is the Operating Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Operating Income has been 42%. The projected CAGR for the next 8 years is 15%.
What is the Pre-Tax Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
21%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 47%. The projected CAGR for the next 3 years is 21%.
What is the Net Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
14%
The compound annual growth rate for Net Income over the next 8 years is 14%.
